Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,700,891
+$1,237,248 QoQ
Shares Held
4,753
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,611
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARRET ASSET MANAGEMENT, LLC holds $55,272,630 across 8 Drug Manufacturers - General names. LLY ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
80,403 | $20,419,949 | |
| 2 | ABBV |
AbbVie Inc.
|
50,635 | $12,741,791 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,520 | $10,089,820 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
4,753 | $5,700,891 | |
| 5 | PFE |
Pfizer Inc
|
95,897 | $2,309,199 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
39,339 | $2,266,713 | |
| 7 | AMGN |
Amgen Inc
|
3,979 | $1,440,875 | |
| 8 | AZN |
Astrazeneca PLC
|
1,600 | $303,392 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,700,891 | 4,753 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,463,643 | 4,853 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,269,156 | 4,903 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,847,809 | 5,043 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,094,871 | 5,253 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,342,634 | 5,258 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,031,384 | 5,222 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,847,863 | 5,472 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,461,252 | 6,032 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,803,125 | 6,174 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,826,286 | 6,564 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,521,961 | 6,557 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,356,489 | 7,157 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,444,120 | 7,117 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,621,975 | 7,167 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $2,317,449 | 7,167 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,356,179 | 7,267 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,076,755 | 7,252 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $2,003,147 | 7,252 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $1,675,574 | 7,252 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,756,287 | 7,652 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,429,546 | 7,652 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $1,291,963 | 7,652 | Shares | Sole | 2021-03-16 | |
| 2020-09-30 | $1,132,649 | 7,652 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,272,395 | 7,750 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,075,080 | 7,750 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||